For Immediate Release
Chicago, IL – September 24, 2021 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
5 Top-Ranked Stocks on Sale Right Now
Welcome to Episode #252 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks
Value Investor portfolio
, shares some of her top value investing tips and stock picks.
Although the major stock indexes may only be a few percent off their all-time highs, some stocks have corrected much more.
It’s not unusual for some stocks to be down 10%, 20% or even more.
That means some stocks are on sale.
But how do value investors find the best quality stocks that are also a buying opportunity?
Screening for Stocks on Sale
To screen for stocks with quality, include the Zacks Rank of #1 (Strong Buy) or #2 (Buy).
The top Zacks Rank usually means that Wall Street analysts are revising earnings estimates higher.
Zacks Screener on Zacks.com also includes a “price as a % of 52-week high-low range” option.
That means you can screen for stocks within, say, 10% of their 52-week high but you can also look for stocks within 10% of their 52-week lows.
How many stocks have both the top Zacks Ranks and are near their 52-week lows?
36 stocks have this disconnect.
It’s rare.
5 Top Ranked Stocks that are on Sale Right Now
1.
Nu Skin Enterprises, Inc.
NUS
has fallen 28% in the last 3 months and is now at a new 52-week low. This beauty and wellness company does a lot of business in Asia which is making traders nervous due to the coronavirus outbreak there. But the analysts are holding firm on 2021 and 2022 earnings estimates, for now. It’s cheap, with a forward P/E of just 9.4.
2.
VF Corporation
VFC
owns some of the hottest retail brands in Vans, North Face and Timberland. But shares are down 22.5% year-to-date and are at new 52-week lows. Yet earnings are expected to rise 150% this fiscal year and 16.3% next year. It trades with a PEG ratio of just 0.8, including there is both growth and value.
3.
Yamana Gold
AUY
, a gold miner, has slid 27.8% year-to-date. It will trade with the gold price. 4 estimates have been revised higher over the last 60 days. Shares are cheap, with a forward P/E of just 13.1.
4.
Meritor
MTOR
is a global supplier of drivetrain, mobility, braking, aftermarket and electric powertrain solutions. Earnings are expected to soar 118% in fiscal 2021 and another 54% in fiscal 2022. 2 estimates were revised higher for both years in the last 2 months. No estimates have been cut. It’s cheap, with a forward P/E of just 8.5 as shares have fallen 22.9% year-to-date.
5.
Vertex Pharmaceuticals
VRTX
is a large cap drug manufacturer. Shares are down 22% year-to-date as it trades within 1% of its 52-week low. Yet it’s supposed to grow earnings by 19.9% in 2021 and another 6.2% in 2022. It trades with a forward P/E of just 15.
What else should you know about screening for stocks on sale?
Listen to this week’s podcast to find out.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.
This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit
https://www.zacks.com/performance
for information about the performance numbers displayed in this press release.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out
Zacks’ Marijuana Moneymakers
:
An Investor’s Guide
. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report